{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:33:40Z","timestamp":1776353620244,"version":"3.51.2"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jceh.2025.103441","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T16:47:23Z","timestamp":1765471643000},"page":"103441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["From Adults to Children: Rethinking Albumin Therapy in Pediatric Cirrhosis"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-5751","authenticated-orcid":false,"given":"Vipul","family":"Gautam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jceh.2025.103441_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bpa.2008.11.004","article-title":"Relevance of albumin in modern critical care medicine","volume":"23","author":"Vincent","year":"2009","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.jceh.2025.103441_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/cc13991","article-title":"Albumin administration in the acutely ill: what is new and where next?","volume":"18","author":"Vincent","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jceh.2025.103441_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","article-title":"Albumin in chronic liver disease: structure, functions and therapeutic implications","volume":"10","author":"Spinella","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103441_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5604\/01.3001.0012.0916","article-title":"New insights about albumin and liver disease","volume":"17","author":"Carvalho","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcrc.2015.12.019","article-title":"Role of albumin in diseases associated with severe systemic inflammation: pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis","volume":"33","author":"Artigas","year":"2016","journal-title":"J Crit Care"},{"key":"10.1016\/j.jceh.2025.103441_bib6","doi-asserted-by":"crossref","first-page":"29303","DOI":"10.1074\/jbc.274.41.29303","article-title":"The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties","volume":"274","author":"Dockal","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jceh.2025.103441_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4254\/wjh.v8.i7.345","article-title":"Human albumin solution for patients with cirrhosis and acute on chronic liver failure: beyond simple volume expansion","volume":"8","author":"Valerio","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/IJGM.S102819","article-title":"Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements","volume":"9","author":"Levitt","year":"2016","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jceh.2025.103441_bib9","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00281-009-0160-9","article-title":"Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn","volume":"31","author":"Baker","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jceh.2025.103441_bib11","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjp.0707251","article-title":"Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties","volume":"151","author":"Oettl","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jceh.2025.103441_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2025.103441_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin","volume":"25","author":"Kragh-Hansen","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jceh.2025.103441_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/cs0950459","article-title":"Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion","volume":"95","author":"Quinlan","year":"1998","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jceh.2025.103441_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjp.0707251","article-title":"Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties","volume":"151","author":"Oettl","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jceh.2025.103441_bib17","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1478-3231.2006.01327.x","article-title":"Role of neutrophils in acute inflammatory liver injury","volume":"26","author":"Jaeschke","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103441_bib18","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0008-6363(02)00492-3","article-title":"Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells","volume":"55","author":"Zhang","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jceh.2025.103441_bib19","doi-asserted-by":"crossref","first-page":"C439","DOI":"10.1152\/ajpcell.1993.265.2.C439","article-title":"Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix","volume":"265","author":"Qiao","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jceh.2025.103441_bib20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2014.10.031","article-title":"Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure","volume":"62","author":"Garcia-Martinez","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"APASL ACLF Research Consortium (AARC) for APASL ACLF working party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103441_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2007-1007294","article-title":"Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis","volume":"14","author":"Schrier","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2025.103441_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1440-1746.2008.05461.x","article-title":"Liver disease and the renin-angiotensin system: recent discoveries and clinical implications","volume":"23","author":"Lubel","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3904\/kjim.2017.317","article-title":"Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension","volume":"33","author":"Shim","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jceh.2025.103441_bib25","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/hep.31836","article-title":"Albumin in advanced liver diseases: the good and bad of a drug","volume":"74","author":"Jagdish","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib26","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/hep.31798","article-title":"Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications","volume":"74","author":"Baldassarre","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","article-title":"Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival","volume":"59","author":"Oettl","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1248\/yakushi.14-00166","article-title":"Elucidation of the mechanism responsible for the oxidation of serum albumin and its application in treating oxidative stress-related diseases","volume":"134","author":"Anraku","year":"2014","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jceh.2025.103441_bib29","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/hep.30135","article-title":"Oxidized albumin triggers a cytokine storm in leukocytes through P38 mitogen-activated protein kinase: role in systemic inflammation in decompensated cirrhosis","volume":"68","author":"Alcaraz-Quiles","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1744-9987.12024","article-title":"Human nonmercaptalbumin-2: a novel prognostic marker in chronic liver failure","volume":"18","author":"Stauber","year":"2014","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jceh.2025.103441_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/hep.28897","article-title":"Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis","volume":"65","author":"Das","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib33","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1515\/cclm.2011.675","article-title":"The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease","volume":"49","author":"Chen","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jceh.2025.103441_bib34","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/liv.12860","article-title":"Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis","volume":"35","author":"Giannone","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103441_bib35","first-page":"Bc09","article-title":"The role of ischemia modified albumin as a biomarker in patients with chronic liver disease","volume":"10","author":"Kumar","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jceh.2025.103441_bib36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3906\/sag-1611-66","article-title":"Serum ischemic modified albumin (IMA) concentration and IMA\/albumin ratio in patients with hepatitis brelated chronic liver diseases","volume":"47","author":"Yavuz","year":"2017","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.jceh.2025.103441_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5009\/gnl.2012.6.1.92","article-title":"Ischemia-modified albumin levels in children with chronic liver disease","volume":"6","author":"Cakir","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2025.103441_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcrc.2016.08.005","article-title":"Ischemia-modified albumin is a predictor of short-term mortality in patients with severe sepsis","volume":"37","author":"Yin","year":"2017","journal-title":"J Crit Care"},{"key":"10.1016\/j.jceh.2025.103441_bib39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103441_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cgh.2011.11.012","article-title":"Role of albumin treatment in patients with spontaneous bacterial peritonitis","volume":"10","author":"Poca","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1443-9573.2002.00062.x","article-title":"Efect of albumin infusion on preventing the deterioration of renal function in patients with spontaneous bacterial peritonitis","volume":"3","author":"Xue","year":"2002","journal-title":"Chin J Dig Dis"},{"key":"10.1016\/j.jceh.2025.103441_bib42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fern\u00e1ndez","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365520902719273","article-title":"Efect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"44","author":"Chen","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103441_bib44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2015.06.019","article-title":"Safety, complications and outcome of large volume paracentesis with or without albumin therapy in children with severe ascites due to liver disease","volume":"63","author":"Sarma","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib45","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/295153","article-title":"Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis","volume":"2013","author":"Kwok","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jceh.2025.103441_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2025.103441_bib48","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American association for the study of liver diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib49","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Th\u00e9venot","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis: a randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib51","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jhep.2013.07.020","article-title":"Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study","volume":"59","author":"Simon-Talero","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20030357","article-title":"Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid","volume":"106","author":"Jalan","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.jceh.2025.103441_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fernandez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.103441_bib54","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2025.103441_bib55","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103441_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib57","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365520902719273","article-title":"Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"44","author":"Chen","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103441_bib58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O'Brien","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2025.103441_bib59","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jceh.2014.08.007","article-title":"Role of human albumin in the management of complications of liver cirrhosis","volume":"4","author":"Bernardi","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib60","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib61","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib62","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103441_bib63","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hep.30859","article-title":"Incidence, risk factors, and outcomes of transition of acute kidney injury to chronic kidney disease in cirrhosis: a prospective cohort study","volume":"71","author":"Maiwall","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib64","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1111\/liv.13693","article-title":"Profile, risk factors and outcome of acute kidney injury in paediatric acute-on-chronic liver failure","volume":"38","author":"Lal","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103441_bib65","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1007\/s00431-021-04076-1","article-title":"Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis","volume":"180","author":"Vijay","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jceh.2025.103441_bib66","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2362.1979.tb01669.x","article-title":"Renin, aldosterone and renal haemodynamics in cirrhosis with ascites","volume":"9","author":"Arroyo","year":"1979","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jceh.2025.103441_bib68","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7326\/0003-4819-94-2-198","article-title":"Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites","volume":"94","author":"Arroyo","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2025.103441_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.HYP.1.2.125","article-title":"Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and \u201clow-renin\u201d cirrhosis","volume":"1","author":"Wilkinson","year":"1979","journal-title":"Hypertension"},{"key":"10.1016\/j.jceh.2025.103441_bib70","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2362.2008.02044.x","article-title":"Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis","volume":"38","author":"Kuiper","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jceh.2025.103441_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/jgh.13439","article-title":"Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis","volume":"32","author":"Paternostro","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib72","article-title":"Plasma renin activity predicts prognosis and liver disease-related events in liver cirrhosis patients with ascites treated by tolvaptan","volume":"30","author":"Osawa","year":"2021","journal-title":"Dig Dis"},{"key":"10.1016\/j.jceh.2025.103441_bib73","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","article-title":"Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"41","author":"Fern\u00e1ndez","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib74","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ki.1979.121","article-title":"Renin-angiotension-aldosterone system in the healty infant and child","volume":"16","author":"Acker","year":"1979","journal-title":"Kidney Int"},{"key":"10.1016\/j.jceh.2025.103441_bib75","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/tropej\/fmi060","article-title":"Study of substance P, renin and aldosterone in chronic liver disease in Egyptian children","volume":"51","author":"El-Raziky","year":"2005","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jceh.2025.103441_bib76","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gin\u00e8s","year":"1996","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.jceh.2025.103441_bib77","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.3390\/jcm10214885","article-title":"Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis","volume":"10","author":"Ventura-Cots","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2025.103441_bib78","series-title":"American Association of Study of Liver Disease","article-title":"Management of adult patients with ascites due to cirrhosis: Update 2012","author":"Runyon","year":"2012"},{"key":"10.1016\/j.jceh.2025.103441_bib79","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/295153","article-title":"Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis","volume":"2013","author":"Kwok","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jceh.2025.103441_bib80","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0750-7658(94)80038-3","article-title":"Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study","volume":"13","author":"Laxenaire","year":"1994","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jceh.2025.103441_bib81","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12664-023-01389-x","article-title":"Tolerance of standard dose albumin infused over 6 hours for treatment of spontaneous bacterial peritonitis: a randomized controlled trial","volume":"42","author":"Kar","year":"2023","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103441_bib82","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/HEP.0000000000000521","article-title":"Controversies regarding albumin therapy in cirrhosis","volume":"81","author":"Trebicka","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103441_bib83","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jhep.2022.03.005","article-title":"Long-term albumin treatment in patients with cirrhosis and ascites","volume":"76","author":"Caraceni","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103441_bib84","first-page":"CD004039","article-title":"Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis","volume":"6","author":"Simonetti","year":"2019","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325009417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325009417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:38:39Z","timestamp":1773905919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325009417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0973688325009417"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103441","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From Adults to Children: Rethinking Albumin Therapy in Pediatric Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103441"}}